Bradykinin in ischemia-reperfusion injury of the rat lung

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 5, 2007, Pages 513-522

  Nowak, Kai ^a,b   Weih, S ^a   Post, S ^a   Gebhard, M M ^a   Hohenberger, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin converting enzyme; Animal model; Bradykinin; Lung ischemia

Indexed keywords

ANGIOTENSIN II; BRADYKININ; BRADYKININ RECEPTOR AGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM LESION; ENZYME ACTIVITY; EXPERIMENTAL LIGATION; HEMODYNAMIC PARAMETERS; IN VIVO STUDY; LUNG ENDOTHELIUM; LUNG HILUS; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGEN TENSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRADYKININ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEART RATE; LUNG; LUNG DISEASES; MALE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; OXYGEN; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; REPERFUSION INJURY; RNA, MESSENGER;

EID: 40449136269     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-1459.
2. Fiser SM, Tribble CG, Long SM et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041-1047.
3. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490-511.
4. Nowak K, Kamler M; Bock M et al. Bronchial artery revascularization affects graft recovery after lung transplantation. Am J Respir Crit Care Med 2002; 165: 216-220.
5. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62: 302-314.
6. Erdos EG. Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 1990; 15Suppl 6: S20-S24.
7. Skidgel RA. Bradykinin-degrading enzymes: Structure, function, distribution, and potential roles in cardiovascular pharmacology. J Cardiovasc Pharmacol 1992; 20Suppl 9: S4-S9.
8. Monsees TK, Blocher,S, Heidorn F et al. Expression and location of the bradykinin B2 receptor in rat testis. Biol Reprod 2002; 67: 1832-1839.
9. Atochina EN, Muzykantov VR, Al-Mehdi AB, Danilov SM, Fisher AB. Normoxic lung ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. Am J Respir Crit Care Med 1997; 156: 1114-1119.
10. Yu J, Prado GN, Taylor L, Pal-Ghosh R, Polgar P. Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction. Int Immunopharmacol 2002; 2002: 1807-1822.
11. Wagner EM, Blosser S, Mitzner W. Bronchial vascular contribution to lung lymph flow. J Appl Physiol 1998; 85: 2190-2195.
12. Souza DG, Pinho V, Pesquero JL et al. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br J Pharmacol 2003; 139: 129-139.
13. Arakawa K, Takeyoshi I, Akao Y, Totsuka O, Matsumoto K, Morishita Y. Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci 2005; 50: 27-36.
14. Hashimoto N, Takeyoshi I, Tsutsumi H et al. Effects of a bradykinin B2 receptor antagonist, FR173657, on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant 2002; 21: 1022-1029.
15. Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myokardial infarction and apoptosis after myokardial ischemia and reperfusion. Hypertension 2000; 35: 25-31.
16. Duncan AM, Burrell L, Kladis A, Campbell DJ. Angiotensin and bradykinin peptides in rats with myokardial infarction. J Card Fail 1997; 3: 41-52.
17. Feng J, Sellke ME, Ramlawi B et al. Bradykinin induces microvascular preconditioning through the opening of calcium activated potassium channels. Surgery 2006; 140: 192-197.
18. Oldenburg O, Quin Q, Krieg T et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004; 286: H468-H476.
19. Wollert KC, Studer R, Doerfer K et al. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation, 1997; 95: 1910-1917.
20. Schriefer JA, Broudy EP, Hassen AH. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion. J Pharmacol Exp Ther 2001; 289: 970-973.
21. Nowak K, Weih S, Metzger R et al. Immunotargeting of catalase to lung endothelium via anti-ACE antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am J Physiol Lung Cell Mol Physiol 2007; epub ahead of print.
22. Peinnequin A, Mouret C, Birot O et al. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004; 5:3.
23. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 1995; 92: 3105-3112.
24. Orfanos SE, Armaganiodis A, Glynos C et al. Pulmonary capillary endothelium-bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury. Circulation 2000; 102: 2011-2018.
25. Chen Z, Deddish PA, Minshall RD, Becker RP, Erdos EG, Tan F. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J 2006; 20: 2261-2270.
26. Hashimoto N, Takeyoshi I, Tsutsumi H et al. Effects of a bradykinin B(2) receptor antagonist on ischemia-reperfusion injury in a canine lung transplantation model. J Heart Lung Transplant 2004; 23: 606-613.
27. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA. Pattern of injury and role of neutrophils in reperfusion injury of rat lung. J Surg Res 1995; 58: 713-718.
28. Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM. Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol 2005; 99: 2423-2432.
29. Romanska HM, Ikonen TS, Bishop AE, Morris RE, Polak JM. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease. J Pathol 2000; 191: 71-77.
30. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov V, Fisher AB. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 1999; 85: 682-689.
31. Fisher AB, Dodia C, Ayene I al-Mehdi A. Ischemia-reperfusion injury to the lung. Ann N Y Acad Sci 1994; 723:197-207.